GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (NSE:MANKIND) » Definitions » 1-Year ROIIC %

Mankind Pharma (NSE:MANKIND) 1-Year ROIIC % : 462.66% (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Mankind Pharma's 1-Year ROIIC % for the quarter that ended in Sep. 2024 was 462.66%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Mankind Pharma's 1-Year ROIIC % or its related term are showing as below:

NSE:MANKIND's 1-Year ROIIC % is ranked better than
95.35% of 1010 companies
in the Drug Manufacturers industry
Industry Median: 1.6 vs NSE:MANKIND: 462.66

Mankind Pharma 1-Year ROIIC % Historical Data

The historical data trend for Mankind Pharma's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma 1-Year ROIIC % Chart

Mankind Pharma Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
1-Year ROIIC %
- 30.98 5.05 304.64 182.69

Mankind Pharma Quarterly Data
Mar20 Mar21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 182.69 - 462.66

Competitive Comparison of Mankind Pharma's 1-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mankind Pharma's 1-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's 1-Year ROIIC % falls into.



Mankind Pharma 1-Year ROIIC % Calculation

Mankind Pharma's 1-Year ROIIC % for the quarter that ended in Sep. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( 19374.9482 (Sep. 2024) - 14986.9823 (Sep. 2023) )/( 75961.2 (Sep. 2024) - 75012.783 (Sep. 2023) )
=4387.9659/948.41700000002
=462.66%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Mankind Pharma  (NSE:MANKIND) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Mankind Pharma 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mankind Pharma Business Description

Traded in Other Exchanges
Address
262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020
Mankind Pharma Ltd is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors providing products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News, Gas-O-Fast, AcneStar and HealthOK. Geographically, the company derives a majority of its revenue from the sale of pharmaceutical products in India and the rest from its customers located outside India.

Mankind Pharma Headlines

No Headlines